Filing
Spy
Filing
Spy
Home
About
GILD
Gilead Sciences, Inc.
Biopharmaceutical company
CUSIP: 375558103
Healthcare
US
4 holders
Ownership
Activity
2023 Q2
11 of 52 quarters
Total Value
$1.95B
Total Shares
25.30M
Net Share Change
-17.5K
Activity
2 buying
2 selling
Investor
Value
Shares
Weight
Change
Dodge & Cox Stock Fund
$1.87B
24.24M
2.0%
TRIM
-247.0K
(-1.0%)
Dodge & Cox Stock Fund
$1.87B
24.24M shares
TRIM
-247.0K
(-1.0%)
Bridgewater Associates LP
$57.47M
745.7K
0.4%
ADD
+249.1K
(+50.1%)
Bridgewater Associates LP
$57.47M
745.7K shares
ADD
+249.1K
(+50.1%)
Matrix Asset Advisors
$23.18M
300.7K
3.2%
TRIM
-21.9K
(-6.8%)
Matrix Asset Advisors
$23.18M
300.7K shares
TRIM
-21.9K
(-6.8%)
Pzena Investment Management
$458.2K
5.9K
0.0%
ADD
+2.4K
(+65.4%)
Pzena Investment Management
$458.2K
5.9K shares
ADD
+2.4K
(+65.4%)
GILD — Gilead Sciences, Inc. - FilingSpy